Company
Headquarters: Camberwell, VIC, Australia
Founded: 1910
CEO: Mr. Richard C. Vincent (Accountancy), B.Bus, C.P.A., CPA
A$753.8 Million
AUD as of March 1, 2022
US$550.2 Million
Company | Market Cap (USD) |
---|---|
McKesson Corporation | $75.67 B |
Cencora, Inc. | $43.82 B |
Cardinal Health, Inc. | $23.31 B |
Shanghai Pharmaceuticals Holding Co. Ltd | $8.79 B |
Sinopharm Group Co. Ltd | $8.37 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Australian Pharmaceutical Industries Limited engages in the wholesale distribution and retail of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia, New Zealand, and Asian markets. It offers health and beauty products through a network of Priceline and Priceline Pharmacy franchise stores, company-owned Priceline stores, and Clear Skincare network of clinics. The company also provides non-invasive aesthetic beauty services. Australian Pharmaceutical Industries Limited was incorporated in 1910 and is based in Camberwell, Australia.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Australian Pharmaceutical Industries Limited has the following listings and related stock indices.
Stock: ASX: API wb_incandescent
Pharmaceutical, health and beauty, Wholesale distribution, ManufacturingRetailing
Peter Robinson, Chairman Richard Vincent, CEO